Ustekinumab to treat Crohn's disease
Author:
Publisher
Elsevier BV
Reference91 articles.
1. Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life;Hommes;J Crohns Colitis,2012
2. Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease;Gisbert;Gastroenterol Hepatol,2002
3. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients;Chaparro;Inflamm Bowel Dis,2013
4. Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience;Gonzalez-Lama;Eur J Gastroenterol Hepatol,2012
5. Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease;Gomollon;Gastroenterol Hepatol,2015
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Crohn’s Disease Patients Who Failed Anti-tumor Necrosis Factor-α Treatment in Japan: An Observational Study Utilizing Claims Database;Biological and Pharmaceutical Bulletin;2024-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3